Comparative analysis of pre-Covid19 child immunization rates across 30 European countries and identification of underlying positive societal and system influences.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
24
09
2021
accepted:
27
06
2022
entrez:
3
8
2022
pubmed:
4
8
2022
medline:
6
8
2022
Statut:
epublish
Résumé
This study provides a macro-level societal and health system focused analysis of child vaccination rates in 30 European countries, exploring the effect of context on coverage. The importance of demography and health system attributes on health care delivery are recognized in other fields, but generally overlooked in vaccination. The analysis is based on correlating systematic data built up by the Models of Child Health Appraised (MOCHA) Project with data from international sources, so as to exploit a one-off opportunity to set the analysis within an overall integrated study of primary care services for children, and the learning opportunities of the 'natural European laboratory'. The descriptive analysis shows an overall persistent variation of coverage across vaccines with no specific vaccination having a low rate in all the EU and EEA countries. However, contrasting with this, variation between total uptake per vaccine across Europe suggests that the challenge of low rates is related to country contexts of either policy, delivery, or public perceptions. Econometric analysis aiming to explore whether some population, policy and/or health system characteristics may influence vaccination uptake provides important results-GDP per capita and the level of the population's higher education engagement are positively linked with higher vaccination coverage, whereas mandatory vaccination policy is related to lower uptake rates. The health system characteristics that have a significant positive effect are a cohesive management structure; a high nurse/doctor ratio; and use of practical care delivery reinforcements such as the home-based record and the presence of child components of e-health strategies.
Identifiants
pubmed: 35921275
doi: 10.1371/journal.pone.0271290
pii: PONE-D-21-30876
pmc: PMC9348723
doi:
Substances chimiques
Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0271290Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Eur J Public Health. 2016 Jun;26(3):378-81
pubmed: 26297722
Vaccine. 2014 Jan 3;32(2):284-9
pubmed: 24252698
Vaccine. 2014 Apr 17;32(19):2150-9
pubmed: 24598724
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Jan;63(1):25-31
pubmed: 31802153
BMC Pediatr. 2015 Nov 13;15:180
pubmed: 26563381
Pathog Glob Health. 2019 Oct;113(7):291-296
pubmed: 31868571
BMJ. 2019 Oct 11;367:l5995
pubmed: 31604708
Vaccine. 2018 Oct 22;36(44):6556-6558
pubmed: 28830694
J Public Health Policy. 2019 Jun;40(2):166-179
pubmed: 30894672
Vaccine. 2018 Aug 9;36(33):4979-4992
pubmed: 30037416
Int J Health Plann Manage. 2021 Nov;36(6):1998-2010
pubmed: 34254365
Vaccine. 2017 Sep 5;35(37):4840-4850
pubmed: 28760616
Eur J Public Health. 2020 Aug 1;30(4):693-697
pubmed: 32206800
Eur J Public Health. 2020 Jun 1;30(3):449-455
pubmed: 31642905
Ital J Pediatr. 2018 Jun 14;44(1):67
pubmed: 29898770
Euro Surveill. 2019 Jan;24(2):
pubmed: 30646979